(4-(2-Phenyl-1H-benzo[d]imidazol-1-yl)phenyl)boronic acid, 95.0%, 250mg

1-((4-Amino-2-propylpyrimidin-5-yl)methyl)-2-methylpyridin-1-ium chloride hydrochloride, 95.0%, 25g

5-(chloromethyl)-1-methyl-1H-1,2,4-triazole hydrochloride, 95.0%, 5g

2-(6-(HYDROXYMETHYL)PYRIDIN-2-YL)PROPAN-2-OL, 95.0%, 1g

4-HYDROXY-6-IODO-2-QUINOLINONE, 95.0%, 250mg

1,3,7-Triazaspiro[4.4]nonane-2,4-dione, 98+%, 100mg

1-((3AR,4R,6R,6aR)-6-(hydroxymethyl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)pyrimidine-2,4(1H,3H)-dione, 98.0%, 1g

3-(4-Chlorophenyl)oxetan-3-amine hydrochloride, 95.0%, 100mg

2-(Diphenylphosphino)phenol, 95.0%, 5g

2-Chloro-N-ethyl-5-(trifluoromethyl)pyrimidin-4-amine, 95%, 5g

Methyl 4-(2-Nitro-4-(trifluoromethyl)phenoxy)benzoate, 95.0%, 2g

Alicates de apertura ROTILABO®, Adecuado para, Tapones para encapsular ND 20, 1 Pieza

[5-(acetylamino)-1H-1,2,4-triazol-3-yl]acetic acid, 95.0%, 1g